Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Dallas, Texas, Aug. 23, 2019 (GLOBE NEWSWIRE) -- The thermal management technologies market is evolving rapidly, especially in the case of consumer electronics. Increasing adoption of renewable...
-
APRIL – JUNI (jämfört med samma period föregående år) Nettoomsättningen minskade 42% till 5,4 (9,2) MSEK.Rörelseresultatet minskade till -2,3 (-2,1) MSEK. Rörelsemarginalen minskade till -42,1%...
-
Fellow Finance growth continues according to the company strategy: turnover grew by 29,6% FELLOW FINANCE PLC COMPANY ANNOUNCEMENT 23 AUGUST 2018 AT 8:00 AM 1.1.-30.6.2019 summary ...
-
Kojamo Plc Stock Exchange Release, 23 August 2019 at 8:00 a.m. EEST Kojamo plc’s Half-Year Financial Report 1 January – 30 June 2019 Profitable growth in line with strategy during the first...
-
HOUSTON, Aug. 22, 2019 (GLOBE NEWSWIRE) -- SAExploration Holdings, Inc. (NASDAQ: SAEX, OTCQB: SXPLW) today announced the appointment of industry veteran Michael Faust as interim President of the...
-
HOUSTON, Aug. 22, 2019 (GLOBE NEWSWIRE) -- NCS Multistage Holdings, Inc. (“NCS” or the “Company”) (NASDAQ:NCSM) announced today that the Board of Directors (the “Board”) has appointed Valerie...
-
SPOKANE, Wash., Aug. 22, 2019 (GLOBE NEWSWIRE) -- Avista (NYSE: AVA) has made several annual rate adjustment filings with the Washington Utilities and Transportation Commission (UTC or Commission)...
-
PALO ALTO, Calif., Aug. 22, 2019 (GLOBE NEWSWIRE) -- HP (NYSE: HPQ) Third quarter GAAP diluted net earnings per share ("EPS") of $0.78, above the previously provided outlook of $0.49 to $0.52 per...
-
Enrique Lores appointed President and CEO of HP Inc. effective November 1, 2019 Dion Weisler to step down while remaining a director on the company’s board PALO ALTO, Calif., Aug. 22, 2019 (GLOBE...
-
MONT-SAINT-GUIBERT, Belgium, Aug. 22, 2019 (GLOBE NEWSWIRE) -- Celyad (Euronext Brussels and Paris, and NASDAQ: CYAD), a clinical-stage biopharmaceutical company focused on the development of CAR-T...